Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma.
Nagai H, Shimomura T, Takeuchi M, Hanada S, Komeno T, Sunami K, Hidaka M, Yano T, Kitano K, Yoshida I, Inoue N, Saito A, Horibe K, Motitani S, Ichihara S, Watanabe T, Sawamura M. Nagai H, et al. Among authors: hanada s. Leuk Lymphoma. 2017 Dec;58(12):2845-2851. doi: 10.1080/10428194.2017.1319054. Epub 2017 May 16. Leuk Lymphoma. 2017. PMID: 28509595 Clinical Trial.
Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups.
Kihara R, Watanabe T, Yano T, Uike N, Okamura S, Kawano F, Hanada S, Sunami K, Inoue N, Sawamura M, Yoshida S, Shimomura T, Kitano K, Kojima Y, Horibe K, Nagai H. Kihara R, et al. Among authors: hanada s. Int J Hematol. 2013 Jan;97(1):98-102. doi: 10.1007/s12185-012-1243-2. Epub 2012 Dec 15. Int J Hematol. 2013. PMID: 23243003
Two rare MPL gene mutations in patients with essential thrombocythemia.
Ohashi H, Arita K, Fukami S, Oguri K, Nagai H, Yokozawa T, Hotta T, Hanada S. Ohashi H, et al. Among authors: hanada s. Int J Hematol. 2009 Oct;90(3):431-432. doi: 10.1007/s12185-009-0413-3. Epub 2009 Sep 2. Int J Hematol. 2009. PMID: 19728022 No abstract available.
Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group.
Takenaka T, Shirakawa S, Mikuni C, Sai T, Shimamoto Y, Araki K, Hirano M, Miura A, Ohno Y, Ichimaru M, Hanada S, Inaba S, Konishi H, Toki H, Tajima K, Niimi M, Fukuda H, Shimoyama M. Takenaka T, et al. Among authors: hanada s. Jpn J Clin Oncol. 1999 Oct;29(10):485-9. doi: 10.1093/jjco/29.10.485. Jpn J Clin Oncol. 1999. PMID: 10645803 Clinical Trial.
Treatment and survival among 1594 patients with ATL.
Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, Saburi Y, Miyahara M, Sueoka E, Uike N, Yoshida S, Yamashita K, Tsukasaki K, Suzushima H, Ohno Y, Matsuoka H, Jo T, Amano M, Hino R, Shimokawa M, Kawai K, Suzumiya J, Tamura K; ATL-Prognostic Index Project. Katsuya H, et al. Among authors: hanada s. Blood. 2015 Dec 10;126(24):2570-7. doi: 10.1182/blood-2015-03-632489. Epub 2015 Sep 11. Blood. 2015. PMID: 26361794 Free article.
600 results